TCL Archive In Brief: ACS Begins Narrowing List of Job Applicants; IL-2 Gets BRM Ok; Pitot Resigns McArdle Post January 31, 1992
TCL Archive Centers, Cancer Control Would Get Larger Shares of NCI Increase In House Bill; Grant Total Drops August 28, 1987
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
